ViiV Healthcare bags Rukobia FDA approval for HIV patients with limited treatment options

pharmanewsdaily- July 4, 2020 0

Rukobia FDA approval : ViiV Healthcare said that the US Food and Drug Administration (FDA) has approved Rukobia (fostemsavir), 600 mg extended-release tablets as a ... Read More